A carregar...
JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients
The use of Natalizumab in Multiple Sclerosis (MS) can cause the reactivation of the polyomavirus JC (JCPyV); this may result in the development of progressive multifocal leukoencephalopathy (PML), a rare and usually lethal disease. JCPyV infection is highly prevalent in worldwide population, but the...
Na minha lista:
| Publicado no: | Viruses |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000901/ https://ncbi.nlm.nih.gov/pubmed/33809082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13030468 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|